Moderna to Announce Q3 2025 Financial Results via Conference Call and Webcast

CAMBRIDGE, MA — October 16, 2025 — Leads & Copy — Moderna, Inc. (NASDAQ:MRNA) will host a live conference call and webcast at 8:00 a.m. ET on Thursday, November 6, 2025, to report its third quarter 2025 financial results and provide a corporate update.

A live webcast of the call will be available under “Events and Presentations” in the Investors section of the Moderna website, which can be accessed at https://investors.modernatx.com. The archived webcast will be available on Moderna’s website approximately two hours after the conference call and will be available for one year following the call.

Moderna is a leader in mRNA medicine, reimagining how medicines are made and transforming how diseases are treated and prevented. The company has developed medicines with unprecedented speed and efficiency, including a COVID-19 vaccine. Moderna’s mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, and autoimmune diseases.

Media Contacts

Investors:

Lavina Talukdar

Senior Vice President & Head of Investor Relations

617-209-5834

Lavina.Talukdar@modernatx.com

Source: Moderna, Inc.

×

Welcome!

BiotechReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy.

By Subscribing you will receive Daily Biotech Story Leads via email 10:30 am Mon-Fri.